Brokerage Motilal Oswal issues Q2 reviews after September-quarter results, keeping its ratings on a basket of seven stocks across sectors including pharma, retail, building materials and oil and gas. The coverage highlights potential upside, including for Mahanagar Gas, while also covering names such as GSK Pharma, V2 Retail and Anant Raj, among others.
Across the outlets provided, the emphasis is on Motilal Oswal’s stock research rather than new company announcements. Both sources frame the story around “target prices” and “upside,” indicating that the firm has not changed its overall ratings but is communicating updated or reiterated price expectations for the listed companies. With only these summaries available, the differences between the articles mainly relate to how they describe the scope of the review (the list of companies and the maximum upside mentioned), rather than reflecting competing interpretations of market conditions. The common thread is the brokerage’s post-earnings stance and where investors might find forecast gains.